World Journal of
Pharmaceutical and Life Sciences

PHYTOCHEMICAL AND THERAPEUTIC PROFILE OF ALOE VERA AND CENTELLA ASIATICA IN REGENERATIVE MEDICINE

Rahul Maurya*, Jitendra Kumar Malik, Gyan Singh, Vivek Gupta, Yogesh Bhardwaj

ABSTRACT

Regenerative medicine is rapidly redefining modern therapeutics by focusing on the restoration of damaged tissues
through coordinated processes such as wound healing, cellular regeneration, and extracellular matrix remodeling.
However, current approaches often remain constrained by high costs, safety concerns, and limited long-term
efficacy, prompting a renewed exploration of plant-derived bioactives as next-generation regenerative agents. In
this context, Aloe vera and Centella asiatica emerge as two synergistic botanical candidates with remarkable
potential in tissue engineering and skin regeneration. Aloe vera, enriched with bioactive polysaccharides such as
acemannan along with anthraquinones and micronutrients, functions as a bioactive scaffold that enhances cellular
hydration, modulates inflammation, and accelerates epithelial repair. Conversely, Centella asiatica, a rich source of
triterpenoids including asiaticoside and madecassoside, acts as a molecular regulator of collagen biosynthesis by
stimulating fibroblast proliferation and activating key signaling pathways involved in tissue remodeling. The
convergence of these phytochemicals enables a multi-target regenerative response characterized by antioxidant
defense, cytokine modulation, angiogenesis, and enhanced extracellular matrix deposition. Notably, emerging
evidence suggests that these botanicals can be integrated into advanced delivery systems such as hydrogels,
nanocarriers, and bioengineered scaffolds, thereby bridging traditional medicine with modern regenerative
technologies. This integrative potential positions them as promising candidates for applications ranging from
chronic wound management to anti-aging dermatology. Nevertheless, challenges including phytochemical
variability, lack of standardized formulations, and insufficient large-scale clinical validation continue to limit their
translational applicability. Future research should emphasize molecular-level investigations, formulation
optimization, and clinical trials to unlock their full therapeutic potential in regenerative medicine.

[Full Text Article]   [Download Certificate]